FEATURED COMPANIES
- Cadwell Industries Inc.
- Compumedics Ltd.
- Koninklijke Philips NV
- Masimo Corp.
- Medtronic Plc
- Natus Medical Inc.
- MORE
Neurodiagnostic and Monitoring Devices Market in the US: About this market
The neurodiagnostic and monitoring devices market in the US analysis considers sales ICP monitoring devices, EEG devices, EMG devices, and other products. In 2019, the ICP monitoring devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing number of traumatic brain injury and brain tumor cases will play a significant role in the ICP monitoring devices segment to maintain its market position. Also, our neurodiagnostic and monitoring devices market in the US report looks at factors such as increasing incidences and prevalence of neurological conditions, new product launches, and the growing number of mergers and acquisitions. However, high costs associated with neurodiagnostic and monitoring devices, complications related to neurodiagnostic procedures and monitoring, and frequent product recalls may hamper the growth of the neurodiagnostic and monitoring devices market in the US over the forecast period.
Neurodiagnostic and Monitoring Devices Market in the US: Overview
Increasing incidences and prevalence of neurological conditions
Patients with a comprehensive range of neurological disorders, including epilepsy, stroke, Parkinson's disease, and brain tumors, have a substantial risk of developing a disability. These neurological disorders develop due to several factors such as bacterial and viral infections, genetic factors, and the lack of immune response. Healthcare professionals use neurodiagnostic and monitoring devices such as EEG, EMG, MEG, and ICP to diagnose neurological diseases for further interventions to save the life of the patients. The increasing number of cases of patients with brain tumors and stroke in the US is driving the need for brain hemorrhage treatment. Stroke can also lead to malignant cerebral edema, which increases the intracranial pressure and brain shift. Intracranial pressure can be monitored using ICP monitoring devices. Thus, the growing use of neurodiagnostic and monitoring devices due to the high prevalence of neurological conditions in the US will lead to the expansion of the neurodiagnostic and monitoring devices market in the US at a CAGR of over 7% during the forecast period.
Paradigm shift toward hybrid brain-computer interface
The demand for non-invasive, hybrid brain-computer interface (HBCI) technologies has increased for enhancing and improving the accuracy of neurodiagnostic procedures. EEG is the widely accepted and majorly performed procedure for diagnosis purposes. It is mostly used in combination with other modalities such as EMG and PSG to enhance the number of control commands, improve accuracy, and minimize the signal detection time. HBCI generally combines with one or more brain-computer interface (BCI) signals or human-machine interface (HMI) biosignals, which helps in improving customer satisfaction and boosting system performance. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of a few major players, the neurodiagnostic and monitoring devices market in the US is concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading manufacturers, that include Cadwell Industries Inc., Compumedics Ltd., Koninklijke Philips NV, Masimo Corp., Medtronic Plc, Natus Medical Inc., and Nihon Kohden Corp.
Also, the neurodiagnostic and monitoring devices market in the US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The neurodiagnostic and monitoring devices market in the US analysis considers sales ICP monitoring devices, EEG devices, EMG devices, and other products. In 2019, the ICP monitoring devices segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the growing number of traumatic brain injury and brain tumor cases will play a significant role in the ICP monitoring devices segment to maintain its market position. Also, our neurodiagnostic and monitoring devices market in the US report looks at factors such as increasing incidences and prevalence of neurological conditions, new product launches, and the growing number of mergers and acquisitions. However, high costs associated with neurodiagnostic and monitoring devices, complications related to neurodiagnostic procedures and monitoring, and frequent product recalls may hamper the growth of the neurodiagnostic and monitoring devices market in the US over the forecast period.
Neurodiagnostic and Monitoring Devices Market in the US: Overview
Increasing incidences and prevalence of neurological conditions
Patients with a comprehensive range of neurological disorders, including epilepsy, stroke, Parkinson's disease, and brain tumors, have a substantial risk of developing a disability. These neurological disorders develop due to several factors such as bacterial and viral infections, genetic factors, and the lack of immune response. Healthcare professionals use neurodiagnostic and monitoring devices such as EEG, EMG, MEG, and ICP to diagnose neurological diseases for further interventions to save the life of the patients. The increasing number of cases of patients with brain tumors and stroke in the US is driving the need for brain hemorrhage treatment. Stroke can also lead to malignant cerebral edema, which increases the intracranial pressure and brain shift. Intracranial pressure can be monitored using ICP monitoring devices. Thus, the growing use of neurodiagnostic and monitoring devices due to the high prevalence of neurological conditions in the US will lead to the expansion of the neurodiagnostic and monitoring devices market in the US at a CAGR of over 7% during the forecast period.
Paradigm shift toward hybrid brain-computer interface
The demand for non-invasive, hybrid brain-computer interface (HBCI) technologies has increased for enhancing and improving the accuracy of neurodiagnostic procedures. EEG is the widely accepted and majorly performed procedure for diagnosis purposes. It is mostly used in combination with other modalities such as EMG and PSG to enhance the number of control commands, improve accuracy, and minimize the signal detection time. HBCI generally combines with one or more brain-computer interface (BCI) signals or human-machine interface (HMI) biosignals, which helps in improving customer satisfaction and boosting system performance. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of a few major players, the neurodiagnostic and monitoring devices market in the US is concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading manufacturers, that include Cadwell Industries Inc., Compumedics Ltd., Koninklijke Philips NV, Masimo Corp., Medtronic Plc, Natus Medical Inc., and Nihon Kohden Corp.
Also, the neurodiagnostic and monitoring devices market in the US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Cadwell Industries Inc.
- Compumedics Ltd.
- Koninklijke Philips NV
- Masimo Corp.
- Medtronic Plc
- Natus Medical Inc.
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 08: DECISION FRAMEWORK
PART 09: DRIVERS AND CHALLENGES
Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Product overview
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Country market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Country market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: ICP monitoring devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: ICP monitoring devices - Year-over-year growth 2020-2024 (%)
Exhibit 22: EEG devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: EEG devices - Year-over-year growth 2020-2024 (%)
Exhibit 24: EMG devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 25: EMG devices - Year-over-year growth 2020-2024 (%)
Exhibit 26: Others - Market size and forecast 2019-2024 ($ millions)
Exhibit 27: Others - Year-over-year growth 2020-2024 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Product launch details and market impact analysis
Exhibit 31: Business strategies and their impact analysis
Exhibit 32: Product recalls
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Vendor landscape
Exhibit 35: Landscape disruption
Exhibit 36: Vendors covered
Exhibit 37: Vendor classification
Exhibit 38: Market positioning of vendors
Exhibit 39: Cadwell Industries Inc. - Vendor overview
Exhibit 40: Cadwell Industries Inc. - Product segments
Exhibit 41: Cadwell Industries Inc. - Key offerings
Exhibit 42: Cadwell Industries Inc. - Key customers
Exhibit 43: Compumedics Ltd. - Vendor overview
Exhibit 44: Compumedics Ltd. - Business segments
Exhibit 45: Compumedics Ltd. - Organizational developments
Exhibit 46: Compumedics Ltd. - Geographic focus
Exhibit 47: Compumedics Ltd. - Key offerings
Exhibit 48: Compumedics Ltd. - Key customers
Exhibit 49: Koninklijke Philips NV - Vendor overview
Exhibit 50: Koninklijke Philips NV - Business segments
Exhibit 51: Koninklijke Philips NV - Organizational developments
Exhibit 52: Koninklijke Philips NV - Geographic focus
Exhibit 53: Koninklijke Philips NV - Segment focus
Exhibit 54: Koninklijke Philips NV - Key offerings
Exhibit 55: Koninklijke Philips NV - Key customers
Exhibit 56: Masimo Corp. - Vendor overview
Exhibit 57: Masimo Corp. - Business segments
Exhibit 58: Masimo Corp. - Organizational developments
Exhibit 59: Masimo Corp. - Geographic focus
Exhibit 60: Masimo Corp. - Key offerings
Exhibit 61: Masimo Corp. - Key customers
Exhibit 62: Medtronic Plc - Vendor overview
Exhibit 63: Medtronic Plc - Business segments
Exhibit 64: Medtronic Plc - Organizational developments
Exhibit 65: Medtronic Plc - Geographic focus
Exhibit 66: Medtronic Plc - Segment focus
Exhibit 67: Medtronic Plc - Key offerings
Exhibit 68: Medtronic Plc - Key customers
Exhibit 69: Natus Medical Inc. - Vendor overview
Exhibit 70: Natus Medical Inc. - Business segments
Exhibit 71: Natus Medical Inc. - Organizational developments
Exhibit 72: Natus Medical Inc. - Geographic focus
Exhibit 73: Natus Medical Inc. - Segment focus
Exhibit 74: Natus Medical Inc. - Key offerings
Exhibit 75: Natus Medical Inc. - Key customers
Exhibit 76: Nihon Kohden Corp. - Vendor overview
Exhibit 77: Nihon Kohden Corp. - Business segments
Exhibit 78: Nihon Kohden Corp. - Organizational developments
Exhibit 79: Nihon Kohden Corp. - Geographic focus
Exhibit 80: Nihon Kohden Corp. - Segment focus
Exhibit 81: Nihon Kohden Corp. - Key offerings
Exhibit 82: Nihon Kohden Corp. - Key customers
Exhibit 83: Validation techniques employed for market sizing
Exhibit 84: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Value chain analysis
- Market segmentation analysis
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- ICP monitoring devices - Market size and forecast 2019-2024
- EEG devices - Market size and forecast 2019-2024
- EMG devices - Market size and forecast 2019-2024
- Others - Market size and forecast 2019-2024
- Market opportunity by product
PART 08: DECISION FRAMEWORK
PART 09: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
- Technological advances
- Initiatives to promote neurodiagnostic and monitoring devices
- Paradigm shift toward hybrid brain-computer interface
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Cadwell Industries Inc.
- Compumedics Ltd.
- Koninklijke Philips NV
- Masimo Corp.
- Medtronic Plc
- Natus Medical Inc.
- Nihon Kohden Corp.
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Product overview
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Country market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Country market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: ICP monitoring devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: ICP monitoring devices - Year-over-year growth 2020-2024 (%)
Exhibit 22: EEG devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: EEG devices - Year-over-year growth 2020-2024 (%)
Exhibit 24: EMG devices - Market size and forecast 2019-2024 ($ millions)
Exhibit 25: EMG devices - Year-over-year growth 2020-2024 (%)
Exhibit 26: Others - Market size and forecast 2019-2024 ($ millions)
Exhibit 27: Others - Year-over-year growth 2020-2024 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Product launch details and market impact analysis
Exhibit 31: Business strategies and their impact analysis
Exhibit 32: Product recalls
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Vendor landscape
Exhibit 35: Landscape disruption
Exhibit 36: Vendors covered
Exhibit 37: Vendor classification
Exhibit 38: Market positioning of vendors
Exhibit 39: Cadwell Industries Inc. - Vendor overview
Exhibit 40: Cadwell Industries Inc. - Product segments
Exhibit 41: Cadwell Industries Inc. - Key offerings
Exhibit 42: Cadwell Industries Inc. - Key customers
Exhibit 43: Compumedics Ltd. - Vendor overview
Exhibit 44: Compumedics Ltd. - Business segments
Exhibit 45: Compumedics Ltd. - Organizational developments
Exhibit 46: Compumedics Ltd. - Geographic focus
Exhibit 47: Compumedics Ltd. - Key offerings
Exhibit 48: Compumedics Ltd. - Key customers
Exhibit 49: Koninklijke Philips NV - Vendor overview
Exhibit 50: Koninklijke Philips NV - Business segments
Exhibit 51: Koninklijke Philips NV - Organizational developments
Exhibit 52: Koninklijke Philips NV - Geographic focus
Exhibit 53: Koninklijke Philips NV - Segment focus
Exhibit 54: Koninklijke Philips NV - Key offerings
Exhibit 55: Koninklijke Philips NV - Key customers
Exhibit 56: Masimo Corp. - Vendor overview
Exhibit 57: Masimo Corp. - Business segments
Exhibit 58: Masimo Corp. - Organizational developments
Exhibit 59: Masimo Corp. - Geographic focus
Exhibit 60: Masimo Corp. - Key offerings
Exhibit 61: Masimo Corp. - Key customers
Exhibit 62: Medtronic Plc - Vendor overview
Exhibit 63: Medtronic Plc - Business segments
Exhibit 64: Medtronic Plc - Organizational developments
Exhibit 65: Medtronic Plc - Geographic focus
Exhibit 66: Medtronic Plc - Segment focus
Exhibit 67: Medtronic Plc - Key offerings
Exhibit 68: Medtronic Plc - Key customers
Exhibit 69: Natus Medical Inc. - Vendor overview
Exhibit 70: Natus Medical Inc. - Business segments
Exhibit 71: Natus Medical Inc. - Organizational developments
Exhibit 72: Natus Medical Inc. - Geographic focus
Exhibit 73: Natus Medical Inc. - Segment focus
Exhibit 74: Natus Medical Inc. - Key offerings
Exhibit 75: Natus Medical Inc. - Key customers
Exhibit 76: Nihon Kohden Corp. - Vendor overview
Exhibit 77: Nihon Kohden Corp. - Business segments
Exhibit 78: Nihon Kohden Corp. - Organizational developments
Exhibit 79: Nihon Kohden Corp. - Geographic focus
Exhibit 80: Nihon Kohden Corp. - Segment focus
Exhibit 81: Nihon Kohden Corp. - Key offerings
Exhibit 82: Nihon Kohden Corp. - Key customers
Exhibit 83: Validation techniques employed for market sizing
Exhibit 84: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Cadwell Industries Inc.
- Compumedics Ltd.
- Koninklijke Philips NV
- Masimo Corp.
- Medtronic Plc
- Natus Medical Inc.
- MORE
The following companies as the key players in the neurodiagnostic and monitoring devices market in the US: Cadwell Industries Inc., Compumedics Ltd., Koninklijke Philips NV, Masimo Corp., Medtronic Plc, Natus Medical Inc., and Nihon Kohden Corp.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the paradigm shift toward hybrid brain-computer interface.”
According to the report, one of the major drivers for this market is the increasing incidences and prevalence of neurological conditions.
Further, the report states that one of the major factors hindering the growth of this market is the frequent product recalls.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the paradigm shift toward hybrid brain-computer interface.”
According to the report, one of the major drivers for this market is the increasing incidences and prevalence of neurological conditions.
Further, the report states that one of the major factors hindering the growth of this market is the frequent product recalls.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
- Cadwell Industries Inc.
- Compumedics Ltd.
- Koninklijke Philips NV
- Masimo Corp.
- Medtronic Plc
- Natus Medical Inc.
- Nihon Kohden Corp.
Note: Product cover images may vary from those shown
LOADING...
